Mereo BioPharma Group Plc (MREO)
0.2755
+0.01
(+3.11%)
USD |
NASDAQ |
Sep 03, 16:00
0.2755
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Cash from Investing (Quarterly) : -0.0004M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0004M |
| March 31, 2026 | -0.2995M |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.3027M |
| June 30, 2025 | -0.0015M |
| Date | Value |
|---|---|
| March 31, 2025 | -0.3212M |
| December 31, 2024 | 0.0028M |
| September 30, 2024 | -0.0029M |
| June 30, 2024 | 0.0004M |
| March 31, 2024 | -0.6996M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0453M |
| BioNTech SE | -118.82M |
| Silence Therapeutics Plc | 64.78M |
| Autolus Therapeutics Plc | 68.03M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.048M |
| Free Cash Flow | -25.58M |
| Free Cash Flow Per Share (Quarterly) | -0.0376 |
| Free Cash Flow to Equity (Quarterly) | -7.079M |
| Free Cash Flow to Firm (Quarterly) | -6.049M |
| Free Cash Flow Yield | -58.01% |